hematologic malignancy
Showing NaN - NaN of 8
CB-Long-Term Safety Study (CB-LTSS)
Enrolling by invitation
- Lymphoma, Non-Hodgkin
- +7 more
- Allogeneic CAR-T therapy
-
Irvine, California
- +3 more
Nov 18, 2022
Diagnostic Performance of PointCheck in Pediatric Population
Recruiting
- Hematologic Malignancy
- PointCheck
-
Houston, TexasMD Anderson Cancer Center
Aug 16, 2022
Hematologic Malignancy, AML, ALL Trial in Australia, United States (Tagraxofusp, Fludarabine, Cytarabine)
Not yet recruiting
- Hematologic Malignancy
- +10 more
- Tagraxofusp
- +8 more
-
Los Angeles, California
- +28 more
Jul 26, 2022
Thrombocytopenia, Hematologic Malignancy, Bone Marrow Aplasia Trial in Israel, Norway, United States (Thrombosomes, Liquid
Suspended
- Thrombocytopenia
- +5 more
- Thrombosomes
- Liquid Stored Platelets (LSP)
-
Duarte, California
- +5 more
Apr 21, 2022
Hematologic Malignancy, Solid Tumor Trial in Houston (Voraxaze (Glucarpidase), Placebo)
Terminated
- Hematologic Malignancy
- Solid Tumor
- Voraxaze (Glucarpidase)
- Placebo
-
Houston, TexasU.T. M.D. Anderson Cancer Center
Dec 4, 2012
Fatigue in Emergency Center Patients
Terminated
- Advanced Cancer
- +2 more
- Surveys
-
Houston, TexasU.T.M.D. Anderson Cancer Center
Jul 26, 2012